Rhythm Pharmaceuticals, Inc.RYTMNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-44.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-44.9%/yr
Quarterly compound
Percentile
P64
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.63% |
| Q3 2025 | -14.19% |
| Q2 2025 | 42.22% |
| Q1 2025 | -114.12% |
| Q4 2024 | 25.26% |
| Q3 2024 | 13.28% |
| Q2 2024 | 28.64% |
| Q1 2024 | -38.66% |
| Q4 2023 | -0.45% |
| Q3 2023 | 28.81% |
| Q2 2023 | -12.78% |
| Q1 2023 | -7.16% |
| Q4 2022 | 27.64% |
| Q3 2022 | -21.07% |
| Q2 2022 | 27.64% |
| Q1 2022 | -32.52% |
| Q4 2021 | -0.78% |
| Q3 2021 | -26.13% |
| Q2 2021 | 5.04% |
| Q1 2021 | -15.14% |
| Q4 2020 | -7.74% |
| Q3 2020 | 9.08% |
| Q2 2020 | 17.64% |
| Q1 2020 | -12.03% |
| Q4 2019 | 4.12% |
| Q3 2019 | -31.55% |
| Q2 2019 | 18.59% |
| Q1 2019 | -49.54% |
| Q4 2018 | -23.85% |
| Q3 2018 | -35.75% |
| Q2 2018 | -7.12% |
| Q1 2018 | -47.76% |
| Q4 2017 | 6.32% |
| Q3 2017 | -37.04% |
| Q2 2017 | 12.46% |
| Q1 2017 | -13.55% |
| Q4 2016 | -39.07% |
| Q3 2016 | 28.45% |
| Q2 2016 | 2.77% |
| Q1 2016 | -74.46% |